logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Keisuke Kataoka

National Cancer Center Research Institute
H指数:49
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease

间充质基质细胞与抗胸腺细胞球蛋白作为急性移植物抗宿主病二线治疗的回顾性比较

Cytotherapy
IF3.2
2026-06-110
OAAI
Makoto Murata; Seitaro Terakura; Junya Kanda; Naoyuki Uchida; Satoshi Yoshihara; Takahiro Fukuda; Keisuke Kataoka; Atsushi Wake; Noriko Doki; Shuichi Ota; Maho Sato; Masahito Tokunaga; Yasuo Mori; Hirohisa Nakamae; Moeko Hino; Makoto Onizuka; Ken Tabuchi; Yoshiko Atsuta; Takanori Teshima
Real-world clinical utility of comprehensive genomic profiling in advanced solid tumors

Saito, Y.; Horie, S.; Kogure, Y.; Mizuno, K.; Ito, Y.; Mizukami, Y.; Kim, H.; Tamura, Z.; Koya, J.; Funakoshi, T.; et al. 高级别实体瘤中全面基因组分析的实时临床应用价值。Nat. Med. 2026, 32, 690–701. [Google Scholar] [CrossRef] [PubMed]

Nature Medicine
IF50
2026-01-060
OAAI
Yuki Saito; Sara Horie; Yasunori Kogure; Kota Mizuno; Yuta Ito; Yosuke Mizukami; Haryoon Kim; Zen Tamura; Junji Koya; Takeru Funakoshi; Kenro Hirata; Keisuke Kataoka
EP300 deficiency leads to chronic replication stress mediated by defective replication fork protection

EP300缺陷导致由复制叉保护缺陷介导的慢性复制应激

Nature Communications
IF15.7
2025-12-070
OAAI
Angelica Barreto-Galvez; Mrunmai Niljikar; Julia Elizabeth Gagliardi; Carolina Plasencia Guzman; Ranran Zhang; Vasudha Kumar; Aastha Juwarwala; Archana Pradeep; Ankit Saxena; Cristina Montagna; Priya Mittal; Jeannine Gerhardt; Bing Xia; Jian Cao; Keisuke Kataoka; Adam David Durbin; Jun Qi; B. Hilda Ye; Advaitha Madireddy
The Limited Impact of Pre-existing Rheumatologic Diseases on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Propensity–Score Matched Analysis

自身免疫性疾病对异基因造血干细胞移植预后的有限影响：一项全国性倾向性评分匹配分析

Transplantation and Cellular Therapy
IF4.4
2025-11-050
PRE
Norina Tanaka; Akihito Shinohara; Shun-Ichi Kimura; Shinichi Kobayashi; Naoyuki Uchida; Noboru Asada; Shuichi Ota; Masatsugu Tanaka; Yasuyuki Arai; Keisuke Kataoka; Maki Hagihara; Makoto Onizuka; Yukinori Nakamura; Ken-ichi Matsuoka; Koji Kawamura; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Hideki Nakasone
Persistent Unilateral Pleural Effusion with Chimeric Antigen Receptor T-cell Infiltration in Primary Mediastinal Large B-cell Lymphoma

持续性单侧胸腔积液伴嵌合抗原受体T细胞浸润的原发纵隔大B细胞淋巴瘤

INTERNAL MEDICINE
IF1.1
2025-10-011
OAAI
Hayashi, Hiroyoshi; Sakurai, Masatoshi; Sakamoto, Miki; Shindo, Takahide; Koya, Junji; Shiozawa, Yuka; Masuda, Kyoko; Yamaguchi, Kentaro; Kawase, Honomi; Miyata, Jun; Matsushita, Hiromichi; Yamazaki, Rie; Koda, Yuya; Kato, Jun; Kataoka, Keisuke
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation

先期实体瘤及其治疗模式对异基因造血干细胞移植后结局的影响

Bone Marrow Transplantation
IF5.2
2025-09-150
PRE
Takayuki Fujii; Masatoshi Sakurai; Hiroaki Shimizu; Akihiko Izumi; Kenji Kimura; Katsuhiro Shono; Susumu Tanoue; Yosuke Okada; Shinichi Kako; Shinichiro Matsui; Emiko Sakaida; Atsushi Jinguji; Fumihiko Ouchi; Yuho Najima; Takeshi Kobayashi; Takayoshi Tachibana; Masatsugu Tanaka; Shino Iwata; Makoto Onizuka; Shingo Yano; Kaoru Hatano; Maki Hagihara; Nobuyuki Aotsuka; Shin Fujisawa; Satoshi Takahashi; Nobuhiko Kobayashi; Taku Kikuchi; Keisuke Tanaka; Keisuke Kataoka; Yoshinobu Kanda
Prevalence and outcome of VEXAS syndrome in unrelated hematopoietic cell transplantation for bone marrow failure

VEXAS综合征在非血缘造血细胞移植治疗骨髓衰竭中的患病率与预后

Clinical and Experimental Medicine
IF3.5
2025-08-220
OAAI
Yoshitaka Zaimoku; Tatsuya Imi; Tatsuya Hatada; Hiroki Mizumaki; Hiroki Mura; Hiroki Yoshino; Yui Kano; Miku Kobayashi; Eriko Morishita; Natsumi Fushida; Takashi Matsushita; Keishi Mizuguchi; Hiroko Ikeda; Yasuhito Nannya; Seishi Ogawa; Kazuyoshi Hosomichi; Noriko Doki; Yuta Katayama; Takashi Koike; Ken-ichi Matsuoka; Tetsuya Nishida; Yoshiyuki Takahashi; Keisuke Kataoka; Hideyuki Nakazawa; Yasunori Ueda; Takahiro Fukuda; Tatsuo Ichinohe; Fumihiko Ishimaru; Makoto Onizuka; Yoshiko Atsuta; Toshihiro Miyamoto
Autologous stem cell transplantation from 2011 to 2022 in Japanese patients aged ≥ 65 years with relapsed or refractory diffuse large B-cell lymphoma

2011年至2022年日本≥65岁复发或难治性弥漫大B细胞淋巴瘤患者的自体干细胞移植

Annals of Hematology
IF2.4
2025-07-230
OA
Satoshi Yamasaki; Shohei Mizuno; Kota Yoshifuji; Eri Matsuki; Masashi Sawa; Takashi Akasaka; Naoyuki Uchida; Hitoji Uchiyama; Keisuke Kataoka; Nobuhiro Hiramoto; Yoshinobu Kanda; Kazuya Ishiwata; Toshio Wakayama; Takahiro Fukuda; Makoto Yoshimitsu; Makoto Onizuka; Marie Ohbiki; Yoshiko Atsuta; Ritsuro Suzuki; Shinichi Kako
In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis

体内CRISPR筛选揭示了KMT2D和TP53缺陷在B细胞淋巴瘤发生中的协同作用

Blood Advances
IF7.1
2025-07-210
OAAI
Kentaro Yamaguchi; Junji Koya; Kota Mizuno; Yosuke Mizukami; Kota Yoshifuji; Yuki Saito; Mariko Tabata; Sumito Shingaki; Mitsuhiro Yuasa; Yuta Ito; Kazutaka Nakashima; Kostiantyn Dreval; Ryan D. Morin; Kenichi Chiba; Ai Okada; Yuichi Shiraishi; Koichi Murakami; Yasunori Kogure; Koichi Ohshima; Keisuke Kataoka
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC

急性GVHD第28天治疗反应标准的修订：JSTCT与MAGIC的合作研究

Blood Advances
IF7.1
2025-07-030
OAAI
Yu Akahoshi; Yoshihiro Inamoto; Nikolaos Spyrou; Hideki Nakasone; Marcio A. Diniz; Noboru Asada; Francis Ayuk; Hannah K. Choe; Noriko Doki; Tetsuya Eto; Aaron M. Etra; Elizabeth O. Hexner; Nobuhiro Hiramoto; William J. Hogan; Ernst Holler; Keisuke Kataoka; Toshiro Kawakita; Masatsugu Tanaka; Takashi Tanaka; Naoyuki Uchida; Ingrid Vasova; Satoshi Yoshihara; Fumihiko Ishimaru; Takahiro Fukuda; Yi-Bin Chen; Junya Kanda; Ryotaro Nakamura; Yoshiko Atsuta; James L. M. Ferrara; Yoshinobu Kanda; John E. Levine; Takanori Teshima
Fludarabine Plus Myeloablative Dose of Busulfan Regimen Was Associated with High Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Lymphoma: A Propensity Score-Matched Comparison Study with Fludarabine Plus High-Dose Melphalan

氟达拉滨联合大剂量白消安方案与异基因造血干细胞移植治疗恶性淋巴瘤的高非复发死亡率相关：一项与氟达拉滨联合高剂量美法仑方案的倾向性评分匹配比较研究

Transplantation and Cellular Therapy
IF4.4
2025-06-010
PRE
Akihito Shinohara; Michiho Shindo; Satoshi Yamasaki; Koji Kato; Satoshi Yoshihara; Go Yamamoto; Keisuke Kataoka; Takashi Ikeda; Hikaru Kobayashi; Kentaro Serizawa; Yasuo Mori; Nobuyuki Takayama; Hideyuki Nakazawa; Ayumu Ito; Yuta Katayama; Yoshinobu Kanda; Makoto Yoshimitsu; Takahiro Fukuda; Yoshiko Atsuta; Eisei Kondo
Optimal Depth of the Treatment Response Before Allogeneic Hematopoietic Transplantation for Chronic Myeloid Leukemia in Chronic Phase

异基因造血干细胞移植前慢性粒细胞白血病慢性期的最佳治疗反应深度

AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2025-05-120
PRE
Okada, Y; Kondo, T; Miyazaki, T; Shimazu, Y; Minami, Y; Ouchi, F; Kako, S; Tanaka, M; Nishida, T; Fujiwara, SI; Uchida, N; Nakamae, H; Hasegawa, Y; Kataoka, K; Yano, S; Sakata-Yanagimoto, M; Ito, A; Ishikawa, J; Kanda, Y; Kawamura, K; Fukuda, T; Atsuta, Y; Tachibana, T
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma

TP53和CDKN2A的异常改变定义了结节性T滤泡辅助细胞淋巴瘤患者中一个预后不良的亚群。

LEUKEMIA
IF13.4
2025-05-020
PRE
Ito, Yuta; Shimono, Joji; Kawamoto, Keisuke; Hatanaka, Kanako C.; Kogure, Yasunori; Tabata, Mariko; Saito, Yuki; Mizuno, Kota; Horie, Sara; Mizukami, Yosuke; Koya, Junji; Murakami, Koichi; Teshima, Takanori; Hatanaka, Yutaka; Chiba, Kenichi; Okada, Ai; Shiraishi, Yuichi; Miyoshi, Hiroaki; Matsuno, Yoshihiro; Ohshima, Koichi; Kataoka, Keisuke; Nakagawa, Masao
Improved Transplant Outcomes With Alternative Donors in Myelofibrosis: A 20-Year Japanese Registry Analysis of Donor Sources and the Impact of Ruxolitinib

异基因移植供者来源及鲁索利替尼对骨髓纤维化患者移植结局影响的20年日本注册研究分析

AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2025-05-010
PRE
Sakatoku, K; Nakamae, H; Murata, M; Shimazu, Y; Takenaka, K; Kimura, F; Uchida, N; Nishida, T; Fukuda, T; Doki, N; Ishikawa, J; Sakaida, E; Kataoka, K; Shirane, S; Tanaka, M; Kobayashi, H; Sawa, M; Wakayama, T; Asada, N; Uehara, Y; Yoshimitsu, M; Kanda, J; Ohbiki, M; Atsuta, Y; Tachibana, T
Superior Survival After Unrelated Allogeneic Stem Cell Transplantation With Low-Dose ATG Compared to Low-Dose TBI in Myeloablative Fludarabine/Busulfan-Based Regimen for MDS on Behalf of the Adult MDS Working Group of the JSTCT

代表JSTCT成人MDS工作组，在基于清髓性氟达拉滨/白消安的MDS方案中，与低剂量TBI相比，低剂量ATG的无关异基因干细胞移植后的生存率更高

TRANSPLANTATION AND CELLULAR THERAPY
IF4.4
2025-01-011
PRE
Fujioka, Machiko; Itonaga, Hidehiro; Nakazawa, Hideyuki; Nishida, Tetsuya; Kataoka, Keisuke; Ikeda, Takashi; Kako, Shinichi; Matsuoka, Ken-ichi; Adachi, Koji; Fujiwara, Shin-ichiro; Aotsuka, Nobuyuki; Kawakita, Toshiro; Sakaida, Emiko; Kanda, Yoshinobu; Ichinohe, Tatsuo; Atsuta, Yoshiko; Miyazaki, Yasushi; Ishiyama, Ken

研究方向

暂未获取到该数据
S
Seishi Ogawa
H 指数:113论文数:1,493被引数:5.5万
Y
Yuichi Shiraishi
H 指数:83论文数:695被引数:3.6万
K
Kenichi Chiba
H 指数:63论文数:398被引数:1.8万
S
Satoru Miyano
H 指数:113论文数:1,593被引数:6.9万
K
Kenichi Yoshida
H 指数:87论文数:898被引数:3.3万
Y
Yasunori Kogure
H 指数:16论文数:148被引数:1,533
J
Junji Koya
H 指数:18论文数:167被引数:1,101
M
Masashi Sanada
H 指数:64论文数:435被引数:2.2万
H
Hiroko Tanaka
H 指数:77论文数:539被引数:3.5万
T
Tetsuichi Yoshizato
H 指数:33论文数:323被引数:9,617